Bydureon exenatide or Byetta exenatide are novel GLP-1 (Glucagon-like Peptide-1) incretin mimetic hormone FDA approved for use in type 2 diabetes treatment. Byetta (exenatide) and Bydureon (exenatide) are used in combination therapy to improve blood glucose control in people diagnosed with type 2 diabetes who are taking sulfonylureas, a metformin, a thiazolidinediones (TZDs), a combination of metformin and thiazolidinediones, or a combination of sulfonylureas and metformin.
Tag Archives: Glumetza
The best outcomes for Type 2 diabetes management have been noted when intensive diabetes treatment is initiated early in the course of the diabetes disease. But there are many other treatment options for Type 2 diabetes and one of those is sugar-lowering oral drugs. Metformin is one of those drugs taken to lower blood glucose levels.